Loading Events

« All Events

AI in Drug & Biological Product Development

August 6 @ 3:00 pm - 4:00 pm

Donenemab link https://www.alzheimers.org.uk/blog/what-is-donanemab-alzheimers-drug#:~:text=Donanemab%20is%20given%20to%20patients,treating%20different%20diseases%2C%20like%20cancers.

AI holds great potential to transform how drugs are developed, manufactured, and utilized. As with any innovation, AI use in drug development creates new and unique challenges that require both careful management and a risk-based regulatory framework that is built on sound regulatory science approaches that support innovation. Join us as we explore guiding principles that are being applied by innovators and regulators to promote the responsible use of AI in the development of safe and effective drugs.

Learn from experts about applying principles for good machine learning practices to ensure responsible use of AI in the development of drugs. Drawing on real case examples, we will discuss the rationale for particular approaches, how success was evaluated, what challenges were encountered, options for scaling and wider applicability, and considerations for moving forward.

Register to Attend

Details

Date:
August 6
Time:
3:00 pm - 4:00 pm
Event Category:
Event Tags:
,
Website:
https://duke.zoom.us/meeting/register/tJcrcu-qrTMiHdayh1J3JhkCi6XkvmAIFey6#/registration

Venue

Online
United Kingdom

Organiser

Duke Aging Center
Phone
+1 919-660-7500
Email
ADRC@duke.edu
View Organiser Website

Leave a comment

Your email address will not be published. Required fields are marked *

Get all the support you need sent straight to your inbox. Research news, oppertunities, blogs, podcasts, jobs, events, funding calls and much more – every friday!

No Thanks

Translate »